XORTX Therapeutics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Year	Current	2022	2021	2020	2019
Market Capitalization	57	10	24	-	-
Market Cap Growth	-	-56.89%	-	-	-
Enterprise Value	52	3	13	-0	-1
PE Ratio	-1.87	-1.52	-18.86	-	-
PB Ratio	9.37	2.06	2.36	-	-
P/FCF Ratio	-1.39	-1.20	-5.14	-	-
P/OCF Ratio	-1.40	-1.20	-5.14	-	-
EV/EBITDA Ratio	-1.24	-0.42	-10.00	0.14	1.28
EV/EBIT Ratio	-1.21	-0.42	-9.89	0.13	1.24
EV/FCF Ratio	-0.91	-0.34	-2.69	0.24	2.94
Debt / Equity Ratio	0.00	0.01	-	-	-0.24
Debt / EBITDA Ratio	0.00	-0.01	-	-	-0.09
Debt / FCF Ratio	0.00	-0.01	-	-	-0.20
Quick Ratio	9.28	6.96	26.97	0.18	0.62
Current Ratio	9.44	7.21	28.78	1.99	0.63
Interest Coverage	-	-	-294.16	-100.42	-16.70
Return on Equity (ROE)	-105.30%	-87.50%	-22.90%	-246.00%	-
Return on Assets (ROA)	-85.30%	-61.40%	-16.80%	-76.00%	-
Return on Capital (ROIC)	-141.89%	-189.20%	-27.64%	-108.73%	352.75%
Earnings Yield	-13.63%	-65.97%	-5.30%	-	-
FCF Yield	-18.33%	-83.41%	-19.45%	-	-
Buyback Yield / Dilution	-38.49%	-35.25%	-47.77%	-24.34%	-
Total Shareholder Return	-38.49%	-35.25%	-47.77%	-24.34%	-

Source: Financials are provided by Nasdaq Data Link and sourced from the audited annual (10-K) and quarterly (10-Q) reports submitted to the Securities and Exchange Commission (SEC).